Pharmaceutical Supply – Colchicine Tablets (NSN 6505006874053)

The contract entails the supply of FDA-approved Colchicine Tablets identified by NSN 6505006874053, packaged in bottles and fully compliant with federal pharmaceutical standards and military logistics specifications. These tablets are intended for use by the Department of Defense and must meet all regulatory and quality controls required for federal medical procurement, including proper labeling, shelf-life validation, and adherence to Good Manufacturing Practices. The procurement is managed under the Defense Logistics Agency and is structured as a subcontract tied to the contract SPE2DX25D8022 with delivery order SPE2D926F7373, ensuring integration into broader military pharmaceutical distribution networks. The product falls under NAICS code 325412, which classifies it within pharmaceutical and medicine manufacturing, reinforcing the need for precise production and packaging protocols. While the solicitation number and point of contact details are not provided, the contract’s posting date of July 15, 2026, indicates a forward-looking procurement timeline aligned with the agency’s replenishment and readiness cycles. Performance location details are unspecified but are implicitly tied to DLA’s nationwide distribution infrastructure, with all shipments expected to fulfill military supply chain requirements including traceability, packaging durability, and documentation compliance for DoD inventory and audit purposes.